PET-MR for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast Cancer

NCT01190566 · clinicaltrials.gov ↗
COMPLETED
Status
57
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Seoul National University Hospital

Collaborators